JP2019524844A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019524844A5 JP2019524844A5 JP2019509528A JP2019509528A JP2019524844A5 JP 2019524844 A5 JP2019524844 A5 JP 2019524844A5 JP 2019509528 A JP2019509528 A JP 2019509528A JP 2019509528 A JP2019509528 A JP 2019509528A JP 2019524844 A5 JP2019524844 A5 JP 2019524844A5
- Authority
- JP
- Japan
- Prior art keywords
- hexahydro
- pyrazino
- diazanaphthalene
- compound according
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662377119P | 2016-08-19 | 2016-08-19 | |
| US62/377,119 | 2016-08-19 | ||
| PCT/US2017/047644 WO2018035477A1 (en) | 2016-08-19 | 2017-08-18 | 5-ht2c receptor agonists and compositions and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019524844A JP2019524844A (ja) | 2019-09-05 |
| JP2019524844A5 true JP2019524844A5 (enExample) | 2020-09-24 |
| JP6977024B2 JP6977024B2 (ja) | 2021-12-08 |
Family
ID=59799461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019509528A Expired - Fee Related JP6977024B2 (ja) | 2016-08-19 | 2017-08-18 | ５−ｈｔ２ｃ受容体アゴニストおよび組成物ならびに使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10836764B2 (enExample) |
| EP (1) | EP3500570B1 (enExample) |
| JP (1) | JP6977024B2 (enExample) |
| KR (1) | KR20190049732A (enExample) |
| CN (1) | CN109952301B (enExample) |
| AU (1) | AU2017313908C1 (enExample) |
| BR (1) | BR112019003142A2 (enExample) |
| CA (1) | CA3033142A1 (enExample) |
| EA (1) | EA038219B1 (enExample) |
| IL (1) | IL264682B (enExample) |
| MA (1) | MA45987A (enExample) |
| MX (1) | MX391442B (enExample) |
| NZ (1) | NZ750469A (enExample) |
| WO (1) | WO2018035477A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3033142A1 (en) * | 2016-08-19 | 2018-02-22 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| WO2019131902A1 (ja) | 2017-12-27 | 2019-07-04 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
| JP7337174B2 (ja) | 2018-09-18 | 2023-09-01 | ニカング セラピューティクス， インコーポレイテッド | Ｓｒｃホモロジー－２ホスファターゼ阻害剤としての三置換ヘテロアリール誘導体 |
| WO2020072675A1 (en) | 2018-10-02 | 2020-04-09 | Northwestern University | Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2c (5-ht2c) |
| KR20220008824A (ko) | 2019-04-17 | 2022-01-21 | 컴퍼스 패쓰파인더 리미티드 | 실로시빈으로 불안 장애, 두통 장애 및 섭식 장애를 치료하는 방법 |
| US20230277568A1 (en) * | 2020-07-10 | 2023-09-07 | Eleusis Therapeutics Us, Inc. | Method of treatment for psilocybin or psilocin infusion |
| US11312684B1 (en) | 2021-02-10 | 2022-04-26 | Eleusis Therapeutics Us, Inc. | Pharmaceutically acceptable salts of psilocin and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4597961A (en) | 1985-01-23 | 1986-07-01 | Etscorn Frank T | Transcutaneous application of nicotine |
| US4920989A (en) | 1985-04-25 | 1990-05-01 | Regents Of The University Of California | Method and apparatus for aiding in the reduction of incidence of tobacco smoking |
| IL86170A (en) | 1987-05-01 | 1992-12-01 | Elan Transdermal Ltd | Preparations and compositions comprising nicotine for percutaneous administration |
| US5004610A (en) | 1988-06-14 | 1991-04-02 | Alza Corporation | Subsaturated nicotine transdermal therapeutic system |
| WO1992001029A1 (en) | 1990-07-03 | 1992-01-23 | Quaker Chemical Corporation | Aqueous coolant |
| AU1919592A (en) | 1991-04-16 | 1992-11-17 | National Institutes Of Health | Method of treating trichotillomania and onychophagia |
| GB0202015D0 (en) * | 2002-01-29 | 2002-03-13 | Hoffmann La Roche | Piperazine Derivatives |
| AU2003228485A1 (en) | 2002-04-12 | 2003-10-27 | The University Of Chicago | Farnesoid x-activated receptor agonists |
| JP5520051B2 (ja) * | 2007-11-15 | 2014-06-11 | 武田薬品工業株式会社 | 縮合ピリジン誘導体およびその用途 |
| US8518933B2 (en) * | 2009-04-23 | 2013-08-27 | Abbvie Inc. | Modulators of 5-HT receptors and methods of use thereof |
| KR20180118801A (ko) * | 2010-09-01 | 2018-10-31 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 체중 관리에 유용한 5-ｈｔ2ｃ 작동제의 변형-방출 투여 형태 |
| WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
| WO2015161283A1 (en) * | 2014-04-17 | 2015-10-22 | G1 Therapeutics, Inc. | Tricyclic lactams for use in hspc-sparing treatments for rb-positive abnormal cellular proliferation |
| CA3033142A1 (en) * | 2016-08-19 | 2018-02-22 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
-
2017
- 2017-08-18 CA CA3033142A patent/CA3033142A1/en active Pending
- 2017-08-18 EP EP17762266.9A patent/EP3500570B1/en active Active
- 2017-08-18 EA EA201990527A patent/EA038219B1/ru not_active IP Right Cessation
- 2017-08-18 JP JP2019509528A patent/JP6977024B2/ja not_active Expired - Fee Related
- 2017-08-18 BR BR112019003142-1A patent/BR112019003142A2/pt not_active IP Right Cessation
- 2017-08-18 US US16/326,522 patent/US10836764B2/en active Active
- 2017-08-18 AU AU2017313908A patent/AU2017313908C1/en not_active Ceased
- 2017-08-18 CN CN201780062933.5A patent/CN109952301B/zh not_active Expired - Fee Related
- 2017-08-18 KR KR1020197007503A patent/KR20190049732A/ko not_active Withdrawn
- 2017-08-18 WO PCT/US2017/047644 patent/WO2018035477A1/en not_active Ceased
- 2017-08-18 MA MA045987A patent/MA45987A/fr unknown
- 2017-08-18 MX MX2019002020A patent/MX391442B/es unknown
- 2017-08-18 NZ NZ750469A patent/NZ750469A/en not_active IP Right Cessation
-
2019
- 2019-02-06 IL IL264682A patent/IL264682B/en unknown
-
2020
- 2020-10-19 US US17/073,458 patent/US11608339B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240352031A1 (en) | Thieno[2,3-D]pyrimidin-4-one Derivatives as NMDAR Modulators and Uses Related Thereto | |
| US6376501B1 (en) | Type 2 helper T cell-selective immune response suppressors | |
| US9073936B2 (en) | Organic compounds | |
| KR20010050223A (ko) | Ｃｒｆ 길항제 및 관련 조성물의 용도 | |
| JP2005526691A5 (enExample) | ||
| JP2007508358A5 (enExample) | ||
| US9884872B2 (en) | Organic compounds | |
| RU2350616C2 (ru) | Производные пиразоло- и имидазопиримидина | |
| RU2011108281A (ru) | Трипиридилкарбоксамидные антагонисты орексиновых рецепторов | |
| RU2009147708A (ru) | Производные оксадиазола и их применение в качестве потенцирующих средств метаботропных глутаматных рецепторов-842 | |
| JP2005047930A5 (enExample) | ||
| HUP0002956A2 (hu) | 4-Amino-pirrolo[3,2-d]pirimidin-származékok alkalmazása Y neuropeptid fölösleg okozta megbetegedések gyógyítására szolgáló gyógyszerkészítmények előállítására | |
| KR20070057970A (ko) | 피페리디닐아미노-티에노[2,3-ｄ]피리미딘 화합물 | |
| JP2003525279A5 (enExample) | ||
| JP2015514073A5 (enExample) | ||
| RU2003121307A (ru) | (диазоло-пиридинил)-пиримидины для применения в лечении нарушений центральной нервной системы и диабета | |
| RU2008142841A (ru) | СОЕДИНЕНИЯ ИМИДАЗО-[1, 2-b]-ПИРИДАЗИНА (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЙ ИМИДАЗО-[1, 2-b]-ПИРИДАЗИНА (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ЛЕКАРСТВЕННОЕ СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ И/ИЛИ ПРЕДУПРЕЖДЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С МОДУЛЯЦИЕЙ ГАМКА РЕЦЕПТОРОВ | |
| JP2013523749A5 (enExample) | ||
| JP2010529969A5 (enExample) | ||
| US20220096444A1 (en) | Prophylactic or therapeutic agent for delirium | |
| US10428059B2 (en) | Compounds and methods of treating or ameliorating an IL-1R-mediated disease or disorder using same | |
| CA2301599A1 (en) | Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands | |
| CN101970427A (zh) | 治疗疼痛症状及其它失调的方法 | |
| TWI441631B (zh) | 有效於治療精神障礙之α－胺基醯胺衍生物 | |
| CA2577879A1 (en) | Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i.epsilon. |